￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

News

Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
An effective treatment drug for non-small cell lung cancer—crizotinib (Xalkori)

2025-10-19 11:44:20

Check Details
Is Osimertinib (AZD9291) effective? Is it resistant to long-term use

2025-10-19 11:44:20

Check Details
How effective is afatinib treatment? Does afatinib have many side effects

2025-10-19 11:44:20

Check Details
What should I do if I become resistant to Erlotinib (Tarceva)? What should you pay attention to during treatment

2025-10-19 11:44:20

Check Details
The third "broad-spectrum anti-cancer drug" entrectinib is launched!

2025-10-19 11:44:20

Check Details
What are the dosage and precautions of entrectinib? Does entrectinib have any side effects?

2025-10-19 11:44:20

Check Details
Is erlotinib available in the country? How much does a box of erlotinib cost after medical insurance

2025-10-19 11:44:20

Check Details
How many times a day should I take gefitinib (Iressa)? What is the therapeutic effect of gefitinib

2025-10-19 11:44:20

Check Details
Sotoracib (AMG510) is now on the market~

2025-10-19 11:44:20

Check Details
Amg510 (sotorasiib) for the treatment of KRAS-G12C mutated non-small cell lung cancer

2025-10-19 11:44:20

Check Details
Sotoracib (AMG510) is launched! Patient: High cost performance

2025-10-19 11:44:20

Check Details
Tepotinib, the world's first targeted drug for METex14 mutated lung cancer, was approved in Europe

2025-10-19 11:44:20

Check Details
Category
相关知识